Tuesday 28 February 2017

Biodegradable Stents Market: A Booming trend in Healthcare Analytics Industry

Global Biodegradable Stents Market: Snapshot
The biodegradable stents are used for treating cardiovascular conditions pertaining to the coronary artery. These stents are also known as bioabsorbable or bioresorbable vascular scaffolds and are surgically placed in the coronary artery for eluting the drug that is administered for vascular restoration and the polymer coating. The biggest advantage of these stents is that they get entirely absorbed in the vessels over a period of time, reducing the risk of complications or infections. This advantage is the primary reason for the growth of the global biodegradable stents market. According to the research report, the global biodegradable stents market was valued at US$18 mn in 2015 and is expected to reach US$1.7 bn by 2024, as the market progresses at a CAGR of 30.1% between 2016 and 2024.
Advantages of Biodegradable Stents Keep the Sentiment in Global Market Positive
As compared to predecessors of biodegradable stents, the newer technology has significantly reduced the risk of thrombosis, in in-stent restenosis, dual anti-platelet therapy, and second surgery for removal of the stent. These factors have played a pivotal role in shaping the trajectory of the global market in a positive direction over the past few years. The efficiency of biodegradable stents has won the market numerous consumers in the recent past. Thus, several patients and cardiologists have shown a keen interest in the uptake of biodegradable stents in the treatment of coronary and peripheral artery diseases.
The two type of stents available in the global market are the coronary artery stents and peripheral artery stents. Of these, the coronary artery stents held a dominant share in the global market in 2015. The segment is expected to continue its dominance in the coming years due to the exponentially rising number of deaths due to cardiovascular diseases. The high prevalence of coronary artery diseases across the globe around the world, rising preference of cardiologists towards percutaneous coronary intervention procedures, and increasing uptake of use of stents are expected to make a significant contribution to the soaring revenue of this segment in the forecast period.
Asia Pacific Paces Ahead due to Vast Unmet Medical Needs
In terms of geography, the global biodegradable market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Europe held a lion’s share in the global biodegradable stents market in 2015. Asia Pacific closely followed as the developing nations of the region are showing keen interest in uptake of newer technologies. These regions are expected to show continued progress in the overall market due to high adoption rate of biodegradable stents due to quick approvals from regulatory bodies. Furthermore, high incidence of diabetes and hypertension across Asia Pacific are also expected to spike the demand for biodegradable stents as patients suffering from these conditions are highly susceptible to cardiovascular diseases. The report indicates that North America biodegradable stents market will also show considerable progress with recent approvals from the U.S. FDA.
The key players operating in the global biodegradable stents market are Abbott Laboratories, Boston Scientific, Inc., Kyoto Medical Planning, Biotronik, Elixir Medical Corporation, Sahajanand Medical Technologies, and Terumo Europe NV. The competitive landscape in the global biodegradable stents market is likely to remain consolidated all throughout 2016 and 2024 as major players will hold a dominant share.
Posted by at No comments:
Labels:

Multiplexed Diagnostics Market will grows at a CAGR of 20% with increasing prevalence of cancer and infectious diseases

Global Multiplexed Diagnostics Market: Snapshot
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations. However, the global multiplexed diagnostics market is being restrained by high costs pertaining to multiplexed diagnostics assay equipment and testing and an overall lack of skilled labor for handling the advanced equipment.
The global multiplexed diagnostics market was valued at US$5.0 bn in 2015. It is projected to reach US$26.36 bn by the end of 2024 after expanding at a CAGR of 20% from 2016 to 2024.
North America’s Dominance in Global Multiplexed Diagnostics Market to Continue
The global Multiplexed diagnostics market is segmented on the basis of regions, into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2015, North America bagged for the leading share of the market in terms of value, owing to a rising prevalence of cardiac diseases and cancer in the region. North American players in the multiplexed diagnostics market also benefitted from the greater level of penetration of the national health care services. The region is expected to continue dominating the global multiplexed diagnostics market till 2024, a likelihood attributed to the region’s high percentage of the geriatric population, an advanced and structured healthcare industry, and a large scope of application of reimbursement policies from both public and private sources.
In Europe, the market for multiplexed diagnostics is also expected to grow at a substantial rate with the growing involvement of academic and research institutes from Germany and the U.K. North America and Europe are projected to be highly lucrative markets for players from the global multiplexed diagnostics market. Conversely, multiplexed diagnostics have not yet found solid foundations in Latin America, Asia Pacific, and the Middle East & Africa to grow on for now.
Infectious Disease Diagnostics in Full Swing
In terms of applications, the global multiplexed diagnostics market can be divided into autoimmune diseases, oncology, cardiac diseases, infectious disease diagnostic, and allergies. In 2015, a collective lead was attributed to the two segments of infectious disease diagnostics and oncology, due to an increase in the prevalence of infectious diseases along with a growing count of patients suffering from breast cancer, colorectal cancer, and prostate cancer. Oncology, cardiac diseases, and infectious disease diagnostics are expected to be highly beneficial segments for players from the global multiplexed diagnostics market. The segment for cardiac diseases is expected to expand at leading rate over the coming years due to the growing prevalence of various cardiovascular diseases. In terms of end users, the global multiplexed diagnostics market was led by academic research institutes in 2015. It is also expected to be the dominant end user in the market till 2024, owing to an increasing contribution of universities and cancer research centers and the research projects in the field of genetic engineering.
Till 2015, the leading players in the global multiplexed diagnostics market included Agilent Technologies, Bio-Rad Laboratories, Inc., BioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corporation, Hologic, Inc., Thermo Fisher Scientific, Inc., Siemens Healthineers, and Abbott Laboratories.
Posted by at No comments:
Labels:

U.S. Scar Treatment: 2016 Market Outlook and Forecast up to 2024

U.S. Scar Treatment Market: Overview
Often considered a concept that draws from wound care and first aid, scar treatment has emerged as a niche market promising high growth to medical device manufacturers. However, products used in scar therapy are far more advanced than conventional first-aid adhesives. Driven by innovations, demand in the U.S. scar treatment market is poised to surge exponentially between 2016 and 2024.
A scar is any mark on the skin caused by injury, burns, surgery, acne, or inflammation of tissue. Scars can impact the mental and physical well-being of an individual, resulting in poor self-esteem, depression, embarrassment, and altered social interactions. Scars can be of various types depending on their age, color, shape, and sizes. The incidence of skin problems leading to scar formation is significantly high in the U.S., which is driving the scar treatment market in the country.
Additionally, the U.S. scar treatment market is significantly gaining from the easy availability of technologically advanced products with the capability of fading apparent scars. The growing geriatric population and rising consciousness about appearance among consumers are also aiding the expansion of the scar treatment market in the U.S. Increasing expenditure on personal grooming also has been boosting the U.S. scar treatment market.
A comprehensive overview of the U.S. scar treatment market has been provided in the report. The factors impacting the market’s growth are studied in detail. The report also presents insights into the growth drivers and restraints that are expected to influence the market’s trajectory during the forecast period. Some of the companies operating in the market are profiled in the report to examine the competition prevailing in the U.S. scar treatment market.
U.S. Scar Treatment Market: Key Opportunities and Threats
The increasing disposable income of consumers and rising economic growth are cited as reasons for the revenue generated from the increasing sale of scar treatment products. It is important to note that while the treatment of keloids and burn scars is considered medically important by regulatory bodies, the treatment of mild to medium acne and spot correction is not considered a medical necessity. However, a rise in the affluence of the population has been fuelling the demand for aesthetic corrective procedures such as dermal filling, wrinkle reduction, volume restoration, and laser treatment.
Botulinum type-A injections and hyaluronic acid based dermal fillers are primarily used for aesthetically improving a person’s appearance.
The U.S. scar treatment market is also significantly gaining from the increasing demand for combination therapeutics in scar treatment to enhance the effectiveness of procedures and shorten the time taken for treatment.
The various products available in the U.S. scar treatment market include ointments, creams, gels, oils, and sprays. These products have proven helpful in reducing redness, bumps, pain, and itching caused by scars. Since these products can mostly be applied onto scars without any medical supervision, demand for them is quite high in the U.S. Additionally, the demand for minimally invasive surgical treatments and laser treatments has also significantly increased for the treatment of more severe scars.
On the flip side, some of restraints witnessed by the market include the increasing awareness about the side effects associated with the usage of scar treatment products. The high cost of scar treatment therapies also has an adverse impact on the scar treatment market in the U.S.
U.S. Scar Treatment Market: Competitive Insight
To present insights into the prevailing competition in the U.S. scar treatment market, the report also profiles companies such as Valeant Pharmaceuticals International Inc., Johnson & Johnson Services, Oculus Innovative Sciences, Inc., and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Traveler’s Diarrhea Market: Regional markets, technology developments, types, applications, and the competitive landscape

Traveler’s Diarrhea Market: Overview
Traveler’s diarrhea refers to intestinal and stomach infection and occurs due to unsanitary conditions during handling of food. This disorder is characterized by frequent abdominal cramps resulting in loose stools and is usually caused by consumption of contaminated water or food. Travelling from one place to another where the sanitary conditions, social conditions, climate and other factors are different and hence presents high risk of developing traveler’s diarrhea.
This is one of the most common condition affecting travelers every year, for example according to data enumerated by Centers for Disease Control and Prevention (CDC), around 20% to 50% an estimated 10 million of the international traveler’s develop traveler’s diarrhea every year. This disorder occurs during the travel period or post return and also in some cases one can experience multiple episodes of diarrhea during one trip. Developing countries of Latin America, Middle East, Asia and Africa represent the areas for highest risk of contracting traveler’s diarrhea. Immunosuppressed individuals, young adults and individuals with inflammatory bowel disorders and diabetic patients constitute the highly susceptible patient population for contracting traveler’s diarrhea.
Intensity of infection varies depending on the type of eating establishment. For instance, there is low risk of infection if the food is consumed in private homes and poses high risk of infection in the food from the street vendors. Nausea, vomiting, fever, frequent defecate and abdominal cramps are some of the common symptoms of traveler’s diarrhea. Most of the cases are benign and resolve quickly but sometimes sign and symptoms persist for several days and can be more severe in cases where it is caused by other organisms other than common bacteria. In these cases, prescription medicines are recommended for the treatment. Enterotoxigenic Escherichia coli is the most common causative agent of traveler’s diarrhea. Travelers can minimize the risk of developing traveler’s diarrhea by adopting several preventive measures such as use of bottled drinking water, avoiding consumption of raw or uncooked seafood and meat and raw fruits.
Consulting a doctor than self medication is preferred for the treatment of traveler’s diarrhea and especially relevant to pregnant women and children. There are several medications prescribed for the treatment of diarrhea. For example, Pepto-Bismol tablet shortens the duration of illness and decreases diarrhea. This drug is not advised to take for more than three weeks at a time as it results in certain side effects such as temporary blackening of stools and tongue, constipation, nausea and others. Also, the consumption of this is not recommended for the patients who have aspirin allergy, gout, renal insufficiency and who are already taking anticoagulants. Other treatment options are replacement of fluids and salts achieved by the intake of oral rehydration solutions such as oral rehydration salts (ORS).
The market for traveler’s diarrhea can be analyzed by the various medications available for the treatment and the geographical landscape. Antimicrobial therapy is the most preferred one and fluoroquinolones are the most preferred. The geographical landscape elucidates the analysis of the market by four major geographies namely North America, Asia-Pacific, Europe and Rest of the World. In addition, factors such as side effects of the drugs, introduction of alternate therapies, and increased focus on preventive care would impact the market growth.
Furthermore, regulatory policies, marketing approvals for drugs and safety concerns would further influence the market growth. The major factors favoring the market growth are increasing cases of traveler’s diarrhea and growing tourism across the globe. On the other hand, factors such as side effects of the drugs and lack of accessibility to appropriate treatment might encumber the market growth.
Bayer AG, Johnson & Johnson, Merck & Co., Inc. and Novartis AG are some of the companies operating in this market.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
Posted by at No comments:
Labels:

Pelvic Floor Stimulation Therapy Market: 2016 World Market Outlook and Forecast up to 2024

Pelvic floor stimulation therapy market: Overview
Pelvic floor stimulation (PFS) therapy is a nonsurgical process that activates the nerves and muscle mechanism of the pelvic floor. PFS therapy is frequently prescribed to strengthen the neuromuscular mechanism of the pelvic floor for the treatment of urinary incontinence. With the help of pelvic floor stimulation therapy, patients suffering from urinary incontinence can regain control over their bladder muscle and the muscles around it.
Pelvic floor stimulation therapy involves controlled electrical or magnetic stimulation with non-implantable stimulators to the nerves of the pelvic floor and bladder. The electrodes are placed around the gonads and the rectum or around the anus. The frequency and amplitude of the stimulating pulses, their duration, the number of treatments per day, and the overall duration of the treatment cycle depend on the type and severity of the incontinence. Pelvic floor stimulation therapy exercises the precise muscles involved in the excretion of urine, no surgery is required, and patient participation is also kept to a minimum.
The report offers a comprehensive evaluation of the market by providing in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions.
Pelvic floor stimulation therapy market: Trends and Drivers
Weakening of the pelvis floor muscles, menopause, obesity, constipation, urinary tract infections, and alcoholism are the main causes of urinary incontinence. The increasing prevalence of these conditions, added to the expanding global geriatric population, is the major driver for the global pelvic floor stimulation therapy market. The increasing healthcare awareness among patients and healthcare professionals in developing countries is also driving the demand from the global pelvic floor stimulation therapy market. On the other hand, the high prices of pelvic floor stimulation devices may hinder the growth of the market in the coming years.
Interpret a Competitive outlook Analysis Report with PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12245
According to the U.S. National Institutes of Health, in 2012, approximately 13 million adult women and 6 million adult males above the age of 40 years were suffering from urinary incontinence in the U.S. alone. UK health data suggests that 4 in 100 adult males and 1 in 5 adult women are suffering from this disorder. As per the Canadian Incontinence Foundation, 3.3 million Canadians above the age of 40 years, equating about 10% of the total population, suffer from some kind of urinary incontinence. This has led to government agencies supporting pelvic floor stimulation therapy, which is likely to lead to better reimbursement options and thus increasing demand in the coming years.
Pelvic floor stimulation therapy market: Segmentation
The global pelvic floor stimulation therapy market can be segmented according to geography and type of stimulator. Geographically, the market for pelvic floor stimulation therapy can be segmented into North American, Europe, Asia Pacific and Rest of the World. Of these, North America holds the highest share in the global market, followed by Europe and Asia Pacific.
On the other hand, the market for pelvic floor stimulation therapy can be segmented into two segments by stimulator type, namely electrical devices and magnetic devices. The electric devices segment accounts for a major share due to the established popularity of these devices among clinicians and patients, whereas magnetic devices were introduced relatively recently and are yet to become popular on a large scale.
Pelvic floor stimulation therapy market: Competitive Landscape
There are many companies operating in the global pelvic floor stimulation therapy market, out of which Liberty, Athena, Active Life Technologies, and Mediwatch are the major manufacturers of electrical pelvic floor stimulation devices, while EMD Medical Technologies, MCube Technology and Iskra Medical are the key players in the market for magnetic pelvic floor stimulation devices.
Posted by at No comments:
Labels:

Monday 27 February 2017

Implantable Medical Devices Market: An insight on the important factors and trends influencing the market

The global implantable medical devices market features a largely consolidated competitive landscape, with the top five companies accounting for a share of more than 50% in 2015, reports TMR in a recent report. These companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, Institut Straumann AG, hold sway owing to innovation, rapid introduction of newer and more effective product varieties, and presence across several key regional markets. Being a technology- and research-intensive field, governed by stringent approval regulations, the implantable medical devices market faces a low threat of new entrants in the next few years. However, the introduction of more promising substitutes to traditionally used materials is expected to intensify competition.
Transparency Market Research estimates that the global implantable medical devices market will witness expansion at a healthy 4.9% CAGR over the period between 2016 and 2024. At this pace, the market, which had a valuation of US$32.3 bn in 2015, is expected to rise to US$49.8 bn by 2024. Of the key materials used for manufacturing medical implants, titanium is presently the most preferred but is expected to lose its prominence to other options such as titanium alloys and zirconium. Over the period between 2016 and 2024, the market for titanium implants is expected to expand at a 4.7% CAGR. The markets for titanium alloy implants and zirconium implants are expected to expand at 5.5% and 6.4% CAGR over the same period, respectively.
Rising Prevalence of Chronic Degenerative Disease and Dental Problems to Stimulate Demand for Implantable Medical Devices Globally
A plethora of factors are boosting the global consumption of medical implantable devices. Some of the chief ones of these are the rising numbers of people suffering from chronic degenerative diseases such as arthritis and cardiovascular issues and the high prevalence of dental problems, which could require orthodontic and periodontics interventions. While busy lifestyles, unhealthy dietary habits, lack of physical activities, and rising geriatric population are triggering chronic health diseases, the rising intake of junk/fast food is leading to the increased incidences of dental issues. Over the next few years, these factors are expected to arise as high-impact drivers of the global implantable medical devices.
Along with these factors, the rising prevalence of a number of congenital diseases and the increased awareness and consciousness regarding body’s appearance, and the alleged boost to self-esteem that cosmetic surgeries bring, have also been underlined as the key drivers of the global implantable medical devices market. The increased awareness regarding body aesthetics has given a huge boost to the market for dental surgeries involving implantations, thus driving the global implantable medical devices market.
Concerns Regarding Corrosion, Developments in Surgical Field Threaten to Hurt Demand for Conventional Implants
Studies have demonstrated that implants made from materials such as nickel and chromium are prone to corrosion and can trigger cancers. Implants made from cobalt alloy are known to pose risks to human health owing to in vivo ion release; polyethylene implants could be a potential trigger for bone lysis and localized tissue ruptures. Owing to the potential health issues that many varieties of implants cause, patients are more prone to opt for other alternatives. Along with this, the vast developments in the surgical field could also stimulate the consumer to prefer surgeries that promise minimal risk to health.
Moreover, the high costs of medical implants and the concerns regarding post-implantation infections, which may add to the overall cost of implanting a medical device in the body, are also restraining the overall growth prospects of the global implantable medical devices market to a certain extent.
This review is based on a recent report by Transparency Market Research, titled “Implantable Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024.”
Posted by at No comments:
Labels:

Sunday 26 February 2017

Growing Trends in Spinal Muscular Atrophy Market 2023

According to a new research report released by Transparency Market Research, barring a few drugs, the pipeline for spinal muscular atrophy (SMA) drugs is running dry currently. The few drugs that are present, however, are highly advanced medical technologies progressing through different phases of clinical trials. The key drugs in the spinal muscular atrophy pipeline are RG3039, scAAV9.CB.SMN, CK-2127107, RO6885247, LMI070, Olesoxime (TRO19622), and ISIS-SMNRx.
Ionis Pharma Solution Could Vastly Improve SMA Treatment
ISIS-SMNRx is a drug being developed by Ionis Pharmaceuticals for the treatment of spinal muscular atrophy. As of 2015, it was the only drug that had reached phase 3 of clinical trials. The studies are expected to be completed by July 2017.
“Should this drug be approved for the treatment of spinal muscular atrophy, it will create a highly lucrative opportunity for both Ionis Pharma and Biogen Idec,” states a TMR analyst. “This drug is expected to be released in 2018 and hold high expectations from the healthcare industry for the treatment of spinal muscular atrophy.”
Growing SMA Carrier Frequency Speeds up Solutions R&D
One of the key drivers affecting the growth of the market for spinal muscular atrophy drugs is the increasing number of carriers of the defective SMA gene. As per the findings revealed by CureSMA, nearly one out of 50 people are carrying the SMA defect. Additionally, this statistic does not include a majority of the global population that for various reasons could not be included in the study. The total percentage of SMA gene carriers could therefore be effectively higher than previously mentioned.
This is creating a greater urge for healthcare and pharmaceutical organizations to create feasible solutions to treat spinal muscular atrophy, and is also pushing the organizations to increase awareness rates of SMA among people.
Lack of Advanced Research Slows Overall Development of SMA Treatments
There are currently multiple research institutes and government agencies that are working together to keep the total number of SMA cases in check. They do not, however, distinguish between the various types of spinal muscular atrophy afflicting the patients. This reduces the accuracy of patient diagnosis and eventually reduces the overall rate of development of treatments for spinal muscular atrophy. At the same time, it makes disease mapping for trends extremely difficult.
Interpret a Competitive outlook Analysis Report with PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7187
The resultant lack of research is therefore hindering the chances of innovative treatment solutions and the identification of disease progression.
Large Areas Still Untapped for SMA Treatment to Provide Key Opportunities
The U.S. and Europe have designated SMA as an orphan disease. Between the U.S., Europe and Japan, between 25,000 and 50,000 people were diagnosed with spinal muscular atrophy as of June 2015, according to European Pharmaceutical Reviews. The total number of spinal muscular atrophy patients across the world is as yet unknown.
The absence of an approved drug-based treatment for spinal muscular atrophy combined with the unknown number of SMA patients leaves a major unrealized market for SMA drugs that can be tapped into for greater opportunities.
The information presented in this review is based on a Transparency Market Research report, titled, “Spinal Muscular Atrophy Market - Pipeline Assessment, Size, Growth, Trends, and Forecast 2015 - 2023.”

Posted by at No comments:
Labels:

Oral Contraceptive Pills Market, Research Report, 2015 - 2023

The opportunity in the global oral contraceptive pills market was reported to be US$13.1 bn in 2014 and is anticipated to be worth US$22.9 bn by 2023, registering a steady CAGR of 6.6% therein.
Oral Contraceptive Pills Market: Snapshot
The highly competitive oral contraceptive pills market is marked by the presence of several generic product manufacturers, most of which resort to price reduction and free samples to sustain in the market. Oral contraceptive pills are the most common form of reversible contraception in most developed economies of the world, such as Western Europe, the U.S., Canada, and Australia. The adoption and prescription pattern for oral contraceptive pills varies by region, price, and level of awareness and companies have been taking these factors into consideration to up their share in the market.
Generic Oral Contraceptive Pills Enjoy Larger Share in Global Market
By type of product, the oral contraceptive pills market has been segmented into progestin-only, combination, and others. The combination oral contraceptive pills segment led the overall market in 2014 and is projected to register the highest growth rate over the course of the forecast period. This growth can be attributed to their higher efficiency in preventing pregnancies, their easy availability, and their rising preference among consumers.
On the basis of category, the market is bifurcated into generic oral contraceptive pills and branded pills. In 2014, generic oral contraceptive pills led the overall market and this segment is projected to record the fastest growth rate by 2023. The growth of this segment can be attributed to the widespread adoption of generic contraceptives facilitated by their low prices and ease of use.
Favorable Reimbursement Policies in U.S. Spur Adoption of Oral Contraceptive Pills in North America
The global contraceptive pills market is geographically segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America led the global contraceptive pills market in 2014 primarily owing to a greater incidence of unintended pregnancies in the region. The Centers for Disease Control and Prevention (CDC) states in a study that between 2006 and 2010, a 37% of the total pregnancies in the U.S were unintended. A significant proportion of these pregnancies led to abortions, which resulted in a massive yet preventable healthcare expenditure. In a bid to curb this avoidable healthcare expense, the governments of North American countries are encouraging women to opt for modern and more effective contraceptive options. The enforcement of the Affordable Care Act, or Obamacare, in the U.S. and various awareness programs by non-profit organizations have led to the availability of favorable reimbursement policies and the increased sale of emergency oral contraceptive pills in the region.
Asia Pacific is viewed as one of the most attractive market for oral contraceptive pills in the course of the forecast period thanks to the steady economic development in countries such as Singapore, India, China, Australia, and Philippines. This economic growth has resulted in the increasing disposable income of the people, surging awareness about family planning and contraceptives, and the desire for healthier living. This, in turn, has led to the rising adoption rate of oral contraceptive pills in the region.
The leading players competing in the global oral contraceptive pills market include Bayer AG, Janssen Global Services, LLC, Allergan,plc (Actavis), Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Pfizer, Inc., Merck & Co., Inc., and Mankind Pharma Ltd.
Posted by at No comments:
Labels:

Intracranial Pressure Monitors Market: Business Challenges, Emerging Technologies & Competitive Landscape

Upswing in Brain injuries Demands Increased Application of Intracranial Pressure Monitors
The increased prevalence of traumatic injuries and strokes has laid the ground for the immense rise of the global intracranial pressure monitors market. The upswing in the cases of brain injuries in children as well as adults has also boosted the demand for intracranial pressure monitoring remarkably across the world. However, the biggest influence on this market, which stood at US$0.94 bn in 2014, has been accredited to the substantial shift from invasive pressure monitors to non-invasive pressure monitors. This trend is expected to have an enduring effect on the dynamics of demand and supply of these monitors.
Transparency Market Research expects this market to rise at a CAGR of 6.30% between 2015 and 2023, with business opportunity reaching US$1.63 bn by the end of 2023. Untapped developing countries are anticipated to present opportunity-rich market for participants in the global market for intracranial pressure monitors.
A significant growth can be witnessed in the demand for intracranial pressure monitors with their increasing application in the detection and management of various cerebrovascular disorders such as meningitis, traumatic brain injury, brain tumor, and intracerebral hemorrhage.
In 2013, the traumatic brain injury segment accounted for the biggest share in the demand for intracranial pressure monitors. TMR projects this segment to rise at a rapid CAGR of 7.70% between 2015 and 2023. The increase in violence, rising industrial as well as road accidents, and rising number of reports related to head injuries due to sports and recreational activities are the prime reasons behind the growing prevalence of traumatic brain injuries.
Growing Prevalence of Traumatic Injuries Fuels Demand for Intracranial Pressure Monitors in North America
The market for intracranial pressure monitors stretches across North America, Europe, Asia Pacific, and the Rest of the World. North America has surfaced as the biggest contributor to the intracranial monitor consumption since the past few years. The increasing prevalence of neurological disorders and traumatic injuries have amplified the application of these monitors in this region. Additionally, technical advancements in the field of pressure monitoring are expected to influence the sales volume of these monitors considerably in North America over the coming years.
Although North America will remain the leading regional market for intracranial pressure monitors during the forecast period, Asia Pacific will offer the most profitable opportunities to market players, on account of the presence of a large number of untapped markets.
Apart from this, the augmenting incidence of cerebrovascular disorders, fuelled by the increasing base of geriatric population, and the rising expenditure on healthcare, owing to surging disposable income, are also projected to boost the demand for these monitors in the near future. Europe holds the second position in the worldwide intracranial pressure monitors market.
Integra LifeSciences Corp., Medtronic Inc., and Codman & Shurtleff Inc. are leading the global intracranial pressure monitors market. The collective share of these three companies in the overall market is 53.4%. Other prominent manufacturers of intracranial pressure monitors are Haiying Medical, HeadSense Medical Inc., Raumedic AG, Spiegelberg GmbH & Co. KG., and SOPHYSA.
Posted by at No comments:
Labels:

Skincare Devices Market: Emerging Trends and New Technologies Research 2015 - 2023

Exponential surge in the sale of skincare devices is projected in the forthcoming years. These tools provide a majority of customers with the opportunity to gain from superior beauty outcomes. Skincare devices are designed and developed particularly to ensure efficient diagnosis and treatment of various skin conditions such as dermatological indications and skin cancer. The usage of skincare devices has considerably increased globally due to the rising incidence of cancer. The increasing preference for aesthetic procedures and the willingness of consumers to spend on these procedures will boost prospects for the global skincare devices market.
The most common types of skincare devices available in the market include biopsy devices, dermatoscopes, and image guidance systems. Recently, demand for these devices has significantly increased because of their increasing use in diagnosis of skin lesions suspected to be skin cancers. The incidence of skin cancer is surging globally at an exponential rate. This has compelled an increasing number of patients to undergo diagnosis in form of biopsies and dermatoscopy. The demand for treatment using light therapy and lasabrasion is therefore increasing at a considerable pace. This in turn will translate into higher uptake of skin care devices.
As per Transparency Market Research (TMR), the global skincare devices market is expected to surge at a CAGR of 10.1% between 2015 and 2023. TMR has pegged the market to reach a valuation of US$17,299.4 mn in 2023, from US$7,255.8 in 2014.
North America Emerges as Most Lucrative Regional Market for Skincare Devices
Regionally, emerging economies in Latin America, Eastern Europe, and Asia have been exhibiting the most lucrative prospects for the sale of skincare devices. As of 2014, North America had emerged dominant in the global skincare devices market, trailed by Europe. TMR projects the North America skincare devices market to surge at a CAGR of 9.92% during the forecast period. The region in 2014 held 44.4% of the overall market.
The sale of skincare devices in North America is substantially bolstered by the increasing population of baby boomers in the region. Besides this, the rising aesthetic needs and increasing awareness among customers about their health and well-being have augmented demand for high-performing skincare devices in the region. Technical product developments, paradigm shift in consumer preferences towards non-invasive skincare procedures, and the increasing incidence of skin cancer are other factors fuelling demand for advanced skincare devices from North America.
Asia Pacific however is expected to showcase the highest CAGR of 11.78% during the forecast period. The promising growth in the skincare devices market of the region is attributable largely to the presence of a large population with unmet demand for beauty and wellness.
Increasing Incidence of Cellulite to Fuel Demand for Skincare Devices
Based on application, demand for skincare devices was witnessed to be the highest for cellulite reduction. The segment accounted for a share of 25.1% in 2023. However, during the forecast period, the skin tightening and body contouring segment will exhibit growth at the fastest pace in the market. As per TMR nearly 85% to 98% women are affected by cellulite every year globally. Despite its increasing incidence, cellulite is considered to be an issue of worry by millions of women around the world. Cellulite reduction is thus seen as the largest application segment in the market mainly because of the alarming rise of obesity worldwide, the increasing demand for non-invasive beauty procedures, and increasing willingness of consumers to spend on their beauty and wellness.
Apart from their increasing usage in cellulite reduction, skincare devices are also used for diagnosis and treatment of various skin diseases such as skin cancer, warts, fungal infections, psoriasis, scabies, and others.
Some of the most prominent enterprises operating in the market include Lumenis Ltd., Valeant Pharmaceuticals, Cynosure, ZELTIQ Aesthetics, Inc., and Syneron Medical Ltd.
Posted by at No comments:
Labels:

Friday 24 February 2017

Medical Waste Management Market: Future market projections for forthcoming years

The report on medical waste management market analyzes the current as well as future prospects and various facets of the market in detail. Health care industry serves population by protecting health of individuals and saving lives of many. However, while doing so they generate a lot of waste, which involves risk to people. As the healthcare industry is rapidly growing across the globe and especially in U.S, there will be increasing need for medical waste management and the service providers in the market will witness attractive market opportunities than ever. For the research on this topic, we conducted in-depth interviews and discussions with a wide range of key opinion leaders within medical waste management market, which was supplemented by extensive secondary research.
The market assessment and forecast in terms of revenue (US$ million) for each segment of medical waste management have been provided for the period 2013 to 2023, considering 2014 as the base year. The report also provides the compounded annual growth rate (CAGR %) for the U.S medical waste management market and each sub-segment, for the forecast period 2015 to 2023. Growth rates for each segment within the U.S. medical waste management market have been determined after thorough analysis of past trends, demographics, future trends, technological developments, regulatory requirements.
Factors such as government initiatives, active participation of non-government organizations (NGOs), growing elderly population, growth of pharmaceutical and healthcare industries, and technological innovations would help market players to take strategic decisions in order to strengthen their market positions and inflate their correspondent market shares. The recommendations section included in the report would assist existing market players in targeting all major stakeholders of this industry such as companies. The report also profiles major players in the U.S medical waste management market based on various attributes such as company details, business overview, financial facts, business strategies and recent developments.
Medical waste management market report analyzes the current and future prospects of the U.S market. The medical waste management market comprises medical waste management and pharmaceutical waste management segment. The medical waste management is further segmented as types and services. Under types, medical waste management is divided into sharps waste, infectious and pathological waste, non-infectious waste, radioactive waste, and pharmaceutical waste. The growth of this segment is due to rising awareness programs by private or government bodies to manage non-infectious waste streams. The services segment of medical waste management is further divided into collection, transportation and storage, waste treatment, and disposal method. It is routinely used in daily medical practice by professionals. Hospitals find medical waste management services to be increasingly profitable, as the reach of the services has improved significantly over the years due to the advent of new collection, transportation, storage, treatment, and disposal services. Based on pharmaceutical waste management market is divided into three different parameters such as type (hazardous and non-hazardous), category (controlled and uncontrolled), and substance generators (hospitals, manufacturers, clinical lab, physician office, and reverse distributors).
Additional information such as recent development in medical waste management, market dynamics, porter’s five forces analysis, in the market overview chapter which provide every detail to assist new and existing players to venture and explore latent market opportunities in impending years. This report provides in-depth analysis of the U.S medical waste management market. The stakeholders for this report include companies involved in the research and development and application. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends, and competition for different regions.
However, the market is likely to face some setback due to high initial capital investment cost and intense competition from local players; these might slow down the growth of the market. Nevertheless, the report also highlights various opportunities that are expected to boost the market growth during the forecast period.
The medical waste management market report also includes recommendations section that would assist new companies to enhance their service offerings and expand their market share in the medical waste management market.
Key players profiled in the medical waste management market study encompasses Clean Harbors, Inc., Republic Services Inc., Sharps Compliance, Inc., Stericycle Inc., Suez Environmental Services, U.S. Ecology Inc., Veolia Environmental Services, and Waste Management Inc.
Posted by at No comments:
Labels:

Patient Handling Equipment Market Offering High-growth Opportunities for Market Players

Transparency Market Research has published a new market report titled, “Patient Handling Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024” According to the report, the global patient handling equipment market was valued at US$ 9.5 Bn in 2015 and is anticipated to expand at a CAGR of 10.2% from 2016 to 2024 to reach US$ 22.4 Bn in 2024.
The patient handling equipment market is witnessing various new opportunities such as rental provisions emerging as a market trend among patients who require slings and lifts for short duration (i.e. for four months to six months) in healthcare settings. Moreover, provision for flexible rental payments enables rental providers in effectively managing cash flow throughout the year. These factors would further propel the growth of this market. The major drivers for the market growth include need for prevention of musculoskeletal injuries to both care providers as well as patients due to manual lifting of patients. In such cases, these equipment are considered the right option to lift patients in a proper manner. Secondly, the cost savings on labor will be directed to purchase equipment such as patient lifts, medical beds with assistive technology, and other such equipment, eventually minimizing the role of caregivers in assisting patients. The high benefit to cost ratio for investment made by health care settings will incentivize their adoption rates for patient handling equipment in developed economies.
The research report analyzes the current and future prospects of the patient handling equipment market across the globe during the forecast period from 2016 to 2024. Based on product type, the patient handling equipment market has been categorized into lifting slings, wheelchairs, medical beds, ambulatory aids, shower, bath and toileting equipment, and others comprising patient lifts, transfer assists, lateral and repositioning devices, patient turners, leg lifters, and transfer poles. The report provides market size in terms of US$ Mn, volume (No. of Units), and compound annual growth rate (CAGR %) for each product segment during the forecast period from 2016 to 2024, considering 2014 and 2015 as base years. The report also analyses the patient handling equipment market from an end users perspective, for segments such as Hospital, Nursing Home, Assisted Living Facility, Home Healthcare, and Others (Trauma, paramedical and rehabilitation centers).
Medical bed segment accounted for the largest market share of the global patient handling equipment market in 2015. Considering that medical beds are a mandatory capital investment, for clinical settings, the product segment is expected to witness consistent demand from end users. In addition, an increasing number of high-end super-specialty hospitals are willing to make substantial capital investment for technologically advanced and ergonomically designed medical beds considering the long-term advantages. Patient care often necessitates lifting or providing body movements to perform daily activities such as walking, toileting, and bathing. Such tasks involve handling of patients with proper care. Patient handling equipment are devices used in hospitals and nursing homes to transfer patients with restricted mobility.
Low awareness and apprehensions on return to investment by end-users for expensive technologically advanced equipment are likely to hamper the growth of the market. Developing countries such as India, Sri Lanka etc. are devoid of legal and regulatory protocols pertaining to patient handling for patients as well as caregivers. As a result, the health care system in these regions is fragmented, with presence of small and medium scale end-users devoid of foresighted benefits of patient handling equipment. However, due to political pressures from international bodies aiming to improve health care services across the globe, various countries will be rolling out new policies for developing a patient centered health care system. These government initiatives for improving the quality of patient care and decent work culture for caregivers employed in health care settings is likely to augment the market, especially in Asia Pacific.
The major companies operating in the global patient handling equipment market are ArjoHuntleigh (Getinge Group), DJO Global, V.Guldmann A/S, Hill-Rom Holdings, Inc., Etac AB, Invacare Corporation, Joerns Healthcare LLC, Patterson Medical Holdings, Inc., Permobil AB, Prism Medical, Stiegelmeyer & Co. GMBH, and Stryker Corporation, Sunrise Medical LLC. ArjoHuntleigh (Getinge Group) was identified as the leading player in the global patient handling equipment market in 2015.
Posted by at No comments:
Labels:

Surgical Procedures Volume Market: Industry Overview and Key Factors

The global surgical procedures volume market is dominated by a few players, although they are facing significant competition from local players in respective regional markets. The availability of advanced wound closure material presents a potential threat for the sutures and staples market. However, surgical handheld instruments face major roadblock only from internal substitutes (electrosurgical devices), having no impact on the overall surgical equipment market.
The global surgical procedures volume market was valued at US$1.3 bn in 2014. Expanding at a healthy CAGR of 5.6% during the forecast period of 2015 to 2023, the valuation is estimated to reach US$2.2 bn by the end of 2024.
Vast Population Base makes Asia Pacific Most Profitable Region
On the basis of procedure, the global surgical procedure volume market has been segmented into cardiovascular, orthopedic, neurosurgery, ophthalmic, gynecology, and other procedures, including urology and dental. The ophthalmic procedure segment held the maximum share in the global market in 2014, accounting for US$42.3 bn that year, primarily due to increasing number of ophthalmic surgeries across the globe and the introduction of advanced surgical technologies. However, the gynecology procedure segment is anticipated to grow at a high CAGR of 6.6% during the forecast period. The prominent factors attributed to this growth include a rise in the prevalence of gynecology diseases, changing lifestyle, and surgical up-gradation. The report finds that in 2014, the volume of surgical procedures was 135,986,269, which is anticipated to reach 222,157,438 by 2023.
Geographically, the report studies the regional markets of North America, Europe, Asia Pacific, Latin America, and the Rest of the World. In 2014, Asia Pacific held the maximum market share, at 40.3%, and the region is expected to remain highly prominent during the forecast period. This demand from Asia Pacific is owing to factors such as massive patient base, increasing incidence of cardiovascular diseases, traumatic injuries, neurological disorders, and the introduction of advanced surgical technologies.
Prevalence of Cardiovascular Diseases Driving Demand
Rising geriatric population directly affects the growth and development of cardiac pacemaker products. This is primarily due to the fact that elderly people are highly susceptible to heart diseases such as sick sinus syndrome and atrioventricular blockage. According to the American Heart Association, cardiovascular disease is the leading cause of death globally. Currently, 17.3 million deaths occur per year. A rise in injuries, technological advancements, and rising incidences of cardiovascular, gynecological, neurological, and urological disorders are also seen as factors boosting market growth
Conversely, the rising cost of healthcare as well as complications and infections related to surgical procedures are the factors that may hinder the growth of the global surgical procedures volume market. The shift towards minimally-invasive surgeries is seen as an opportunity in the market.
The author of the report states, “The future of surgery includes making smaller scars, and giving rise to fewer complications. The focus will be on key technologies such as single-incision laparoscopic surgery (SILS).” The author also identifies the development of robotic surgeries for market players to focus on, which is now widely used in operating rooms to perform highly complex and intricate surgeries, with less pain and recovery time.
The information presented in this review is based on a Transparency Market Research report, titled, “Surgical Procedures Volume Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015–2023.”
Posted by at No comments:
Labels:

Tourniquet Market Segment Forecasts up to 2023, Research Reports- TransparencyMarketResearch

According to a new market report published by Transparency Market Research “Tourniquet Market – (By Product – Tourniquet Systems, Tourniquet Cuffs; By Application – Arm Cuffs, Leg cuffs; By End-Users: Hospitals, Physician/Clinic, Non-institutional) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 – 2023” the global tourniquet market was valued at US$ 184.6 Mn in 2014 and is estimated to reach US$ 408.6 Mn by 2023 at a CAGR of 9.3% from 2015 to 2023.
Tourniquet device is a medical equipment which checks excessive bleeding from the affected body part by compressing the blood vessels and nerves. Tourniquet has been identified as one of the most reasonable options for controlling hemorrhages. User-friendly design, durability and low cost are some of the prime factors which increases the demand for tourniquet devices in hospitals and clinics. Increasing incidence of orthopedic injuries, military war injuries, and growing hospital admissions for surgeries are boosting the growth of the tourniquet market.
The global tourniquet market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World, which are further categorized into various countries under each region. North America accounted for the largest market for the global tourniquet market in 2014. Dominance of North America has been attributed to increasing incidence of accidents which leads to serious limb injuries. The use of disposable tourniquet cuffs are on the rise in North America due to the product’s lower price and lesser risk of contamination. In addition, technological advancement associated with tourniquet system and cuffs would have a positive impact on the growth of the tourniquet market. North America comprises Canada and the U.S. North America was the largest market for tourniquet in 2014 primarily due to increasing incidence of road accidents leading to traumatic injuries and rapid introduction of advanced tourniquet devices. Furthermore, major players such as Zimmer Biomet and Stryker Corporation are based in North America. This is likely to boost market growth in the region.
Europe is the second largest market for global tourniquet market in 2014 due to increasing geriatric population undergoing surgeries, high awareness about available tourniquet cuffs, and favorable reimbursement policies. Germany has the largest market share of Europe tourniquet market due to improved health care infrastructure and a developed medical technology market. Factors attributed to the rapid growth of the tourniquet market in Europe are growing trend toward adoption of disposable tourniquet cuffs and increasing incidence of traffic-related injuries, sports injuries, and occupational injuries. The forecast reveals that countries in rest of the Europe would expand at the fastest CAGR during the forecast period.
Asia Pacific was the third largest market for tourniquet devices in 2014, and is anticipated to grow at the highest CAGR during the forecast period. Emerging markets in Asia Pacific hold immense growth potential due to factors such as rise in road accidents, increase in the prevalence of limb surgeries, growing health care expenditure, and improving health care infrastructure. For instance, according to the Central Bureau of Health Intelligence (India), the number of government hospitals in India has increased since year 2000 which is a strong reason for promising growth of the market in Asia Pacific region. Growth in medical tourism and market saturation from North America and Europe is one of the major factors for the increasing demand for tourniquet devices. China was the largest market for tourniquets in Asia Pacific. Presence of large population suffering from orthopedic injuries in countries such as Japan, China, and India adds to the large patient pool. This in turn increases the number of tourniquet cuffs used in surgeries.
The global tourniquet market exhibits intense competition among the existing players. The market is consolidated, characterized by the presence of few established companies. Major players operating in the global tourniquet market are Zimmer Biomet Holdings, Inc., Stryker Corporation, Delfi Medical Innovation, Inc., Hammarplast Medical AB, Pyng Medical Corporation, ulrich Medical, and VBM Medizintechnik GmbH.
Posted by at No comments:
Labels:

Medical Holography Market Outlook to 2026 Report by Transparency Market Research

Biomedical imaging technology is bringing in numerous innovations in the medical technology field. Medical imaging has become one of the fastest growing industries. Medical holography is one such technical advancement in medical science that is expected to answer the most complicated diagnostic issues. A medical hologram produces three dimension (3D) images of the human body in real time images or in the form of video stream. The real time images produced by the medical hologram are of high resolution and would help to reveal the complexities in the diagnosed body. Some of the medical holograms are interactive in nature that also provide most effective user interface for better understanding.
There is a high demand for advanced medical imaging from the healthcare sector. As the innovations in medical education are growing, medical holography market is expected to benefit from these innovations due to increased technology integration. Increased awareness among the consumers related to advanced medical technologies is expected to have a positive influence on medical holography market. Medical holography facilitates the real-time viewing of the diagnosed body, further improving the analysis process. The medical holography system provides an advanced diagnostic methodology to the doctors. These systems offer doctors a better understanding about the anatomy of the patient’s body, driving the demand for medical holography market. Medical holography helps the doctors to view complex displacement of bones or tissues that had occurred. The medical holography system is also expected to help the doctors to understand the medical complications more easily and quickly. Hologram guided heart surgeries are expected to gain more importance during the forecast period. With the help of holograms doctors can easily examine patient’s heart conditions or detect a colon cancer without breaking the skin. It will result in the quick diagnosis of any disease and the doctor can start with his treatment. Furthermore, there are numerous companies across the world investing in medical holography technologies. Introduction of augmented reality in the field of medical holography could be one of the greatest opportunities to the producers of medical holograms. Limited adoption of medical holograms despite its numerous advantages could prove to be a restraining factor for the market. The pricing of such medical holography technology is also higher which could affect its adoption among customers. However, with increasing technology adoption in medical and healthcare sectors this hurdle is expected to be tackled.
The medical holography market can be segmented on the basis of medical hologram types and the technology adopted in medical holography. Volumetric displays, planar/HUD interactive display, segmented displays, static digital holograms are a few of the types of medical holograms. Some of the common technologies viewed in medical holography market are plasma, touchable, electro holographic, semi-transparency, and laser technology.
Some of the key players engaged in medical holography market are Dongguan Linbiao hologram manufacturer, Eon Reality Inc., EchoPixel, Inc., Zebra Imaging, General Electric Company, Microsoft Inc, Provision Holdings Inc., RealView Imaging Ltd., Holographic 3d solutions, Holography Industry JV, Ne&Ro Invest SRL., Arnold Herzig GmbH, DPL Industri A/S Denmark and Olomagic.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)